Catalyst Wire Dossier Catalyst Wire Dossier

Acoltremon

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Acoltremon, covering 2025-12-08 to 2025-12-17. Get the full timeline:

Most recent: Clinical Trial Update: Investigator Initiated Trial Using Dry Eye Surveys to Evaluate and Better Understand FDA Approved Acoltremon Treatment for Dry Eye Disease in Real World Treatment Settings (DESERT) [Phase 4]

See pricing